194 related articles for article (PubMed ID: 26879149)
1. Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain.
Coughlan AM; Harmon C; Whelan S; O'Brien EC; O'Reilly VP; Crotty P; Kelly P; Ryan M; Hickey FB; O'Farrelly C; Little MA
Stem Cells Dev; 2016 Apr; 25(7):530-41. PubMed ID: 26879149
[TBL] [Abstract][Full Text] [Related]
2. Improved B cell development in humanized NOD
Jangalwe S; Shultz LD; Mathew A; Brehm MA
Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
[TBL] [Abstract][Full Text] [Related]
3. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A
Blood; 2011 Mar; 117(11):3076-86. PubMed ID: 21252091
[TBL] [Abstract][Full Text] [Related]
4. Improved multilineage human hematopoietic reconstitution and function in NSGS mice.
Wunderlich M; Chou FS; Sexton C; Presicce P; Chougnet CA; Aliberti J; Mulloy JC
PLoS One; 2018; 13(12):e0209034. PubMed ID: 30540841
[TBL] [Abstract][Full Text] [Related]
5. High activation and skewed T cell differentiation are associated with low IL-17A levels in a hu-PBL-NSG-SGM3 mouse model of HIV infection.
Perdomo-Celis F; Medina-Moreno S; Davis H; Bryant J; Taborda NA; Rugeles MT; Kottilil S; Zapata JC
Clin Exp Immunol; 2020 May; 200(2):185-198. PubMed ID: 31951011
[TBL] [Abstract][Full Text] [Related]
6. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
7. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.
Barve A; Casson L; Krem M; Wunderlich M; Mulloy JC; Beverly LJ
Exp Hematol; 2018 Nov; 67():18-31. PubMed ID: 30125602
[TBL] [Abstract][Full Text] [Related]
8. Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγ null mice is enhanced by transgenic expression of membrane-bound human SCF.
Brehm MA; Racki WJ; Leif J; Burzenski L; Hosur V; Wetmore A; Gott B; Herlihy M; Ignotz R; Dunn R; Shultz LD; Greiner DL
Blood; 2012 Mar; 119(12):2778-88. PubMed ID: 22246028
[TBL] [Abstract][Full Text] [Related]
9. The rate of marrow recovery and extent of donor engraftment following transplantation of ex vivo-expanded bone marrow cells are independently influenced by the cytokines used for expansion.
von Drygalski A; Savatski L; Eastwood D; Klein J; Adamson JW
Stem Cells Dev; 2005 Oct; 14(5):564-75. PubMed ID: 16305341
[TBL] [Abstract][Full Text] [Related]
10. Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors.
Miller PH; Cheung AM; Beer PA; Knapp DJ; Dhillon K; Rabu G; Rostamirad S; Humphries RK; Eaves CJ
Blood; 2013 Jan; 121(5):e1-4. PubMed ID: 23233660
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34
O'Brien LJ; Walpole CM; Leal-Rojas IM; Shatunova S; Moore A; Winkler IG; Guillerey C; Radford KJ
Exp Hematol; 2024 Feb; 130():104134. PubMed ID: 38052261
[TBL] [Abstract][Full Text] [Related]
12. Pathology of macrophage activation syndrome in humanized NSGS mice.
Tarrant JC; Binder ZA; Bugatti M; Vermi W; van den Oord J; Ranieri B; Assenmacher CA; Hoepp N; O'Rourke DM; Shan X; Danet-Desnoyers G; Radaelli E
Res Vet Sci; 2021 Jan; 134():137-146. PubMed ID: 33383491
[TBL] [Abstract][Full Text] [Related]
13. Next-generation humanized NSG-SGM3 mice are highly susceptible to
Hung S; Kasperkowitz A; Kurz F; Dreher L; Diessner J; Ibrahim ES; Schwarz S; Ohlsen K; Hertlein T
Front Immunol; 2023; 14():1127709. PubMed ID: 36969151
[TBL] [Abstract][Full Text] [Related]
14. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
15. Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.
Fujii H; Luo ZJ; Kim HJ; Newbigging S; Gassas A; Keating A; Egeler RM
PLoS One; 2015; 10(7):e0133216. PubMed ID: 26176698
[TBL] [Abstract][Full Text] [Related]
16. Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation.
Takagi S; Saito Y; Hijikata A; Tanaka S; Watanabe T; Hasegawa T; Mochizuki S; Kunisawa J; Kiyono H; Koseki H; Ohara O; Saito T; Taniguchi S; Shultz LD; Ishikawa F
Blood; 2012 Mar; 119(12):2768-77. PubMed ID: 22279057
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of mouse granulocytes and macrophages produced in vitro from bone marrow progenitors stimulated with interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF).
Bender JG; Unverzagt KL; Maples PB; Mehrotra Y; Mellon J; Van Epps DE; Stewart CC
Exp Hematol; 1992 Oct; 20(9):1135-40. PubMed ID: 1361455
[TBL] [Abstract][Full Text] [Related]
18. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
19. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
20. Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts.
Janke LJ; Imai DM; Tillman H; Doty R; Hoenerhoff MJ; Xu JJ; Freeman ZT; Allen P; Fowlkes NW; Iacobucci I; Dickerson K; Mullighan CG; Vogel P; Rehg JE
Vet Pathol; 2021 Jan; 58(1):181-204. PubMed ID: 33208054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
